These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2456340)

  • 1. Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.
    Jelachich ML; Cowan EP; Turner RV; Coligan JE; Biddison WE
    J Immunol; 1988 Aug; 141(4):1108-13. PubMed ID: 2456340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of unique HLA-A2 mutant molecules define epitopes recognized by HLA-A2-specific antibodies and cytotoxic T lymphocytes.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1989 Mar; 142(6):2097-104. PubMed ID: 2466083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single amino acid substitution in HLA-A2 can alter the selection of the cytotoxic T lymphocyte repertoire that responds to influenza virus matrix peptide 55-73.
    Shimojo N; Cowan EP; Engelhard VH; Maloy WL; Coligan JE; Biddison WE
    J Immunol; 1989 Jul; 143(2):558-64. PubMed ID: 2472444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative structural analysis of HLA-A3 antigens distinguishable by cytotoxic T lymphocytes: variant E1.
    van Schravendijk MR; Biddison WE; Berger AE; Coligan JE
    J Immunol; 1985 Jan; 134(1):410-6. PubMed ID: 3871112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of functionally active amino acids involved in the interaction of HLA-A2 or HLA-A3 molecules with cytolytic T lymphocytes.
    Healy F; Sire J; Gomard E; Yssel H; Jordan B; Levy JP
    J Immunol; 1988 Oct; 141(7):2487-96. PubMed ID: 2459213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of amino acid substitutions in the beta-sheet floor and alpha-2 helix of HLA-A2 on recognition by alloreactive viral peptide-specific cytotoxic T lymphocytes.
    Mattson DH; Shimojo N; Cowan EP; Baskin JJ; Turner RV; Shvetsky BD; Coligan JE; Maloy WL; Biddison WE
    J Immunol; 1989 Aug; 143(4):1101-7. PubMed ID: 2473117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and DNA sequence analysis of genes encoding cytotoxic T lymphocyte-defined HLA-A3 subtypes: the E1 subtype.
    Cowan EP; Jordan BR; Coligan JE
    J Immunol; 1985 Oct; 135(4):2835-41. PubMed ID: 2993417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3.
    Hogan KT; Clayberger C; Bernhard EJ; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH
    J Immunol; 1988 Oct; 141(7):2519-25. PubMed ID: 2459215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of point mutations in the native simian virus 40 tumor antigen, and in synthetic peptides corresponding to the H-2Db-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones.
    Deckhut AM; Tevethia SS
    J Immunol; 1992 May; 148(10):3012-20. PubMed ID: 1374447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
    DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
    J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 45 pocket of HLA-A2.1 plays a role in presentation of influenza virus matrix peptide and alloantigens.
    Winter CC; Carreno BM; Turner RV; Koenig S; Biddison WE
    J Immunol; 1991 May; 146(10):3508-12. PubMed ID: 2026879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
    Galocha B; López D; López de Castro JA
    J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of an HLA-A3 gene identifies amino acid 152 as crucial for major-histocompatibility-complex-restricted and alloreactive cytotoxic-T-lymphocyte recognition.
    Cowan EP; Jelachich ML; Coligan JE; Biddison WE
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):5014-8. PubMed ID: 2440039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of HLA epitopes recognized by H-2-restricted cytotoxic T lymphocytes specific for HLA using recombinant genes and synthetic peptides.
    Pala P; Corradin G; Strachan T; Sodoyer R; Jordan BR; Cerottini JC; Maryanski JL
    J Immunol; 1988 Feb; 140(3):871-7. PubMed ID: 2448379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of a kidney-specific peptide recognized by alloreactive HLA-A3-restricted human CTL.
    Poindexter NJ; Naziruddin B; McCourt DW; Mohanakumar T
    J Immunol; 1995 Apr; 154(8):3880-7. PubMed ID: 7535816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line.
    Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL
    J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza virus-specific cytotoxic T cells are restricted by multiple HLA-A3-related self antigens: evidence for recognition of distinct self structures in conjunction with different foreign antigens.
    Biddison WE; Shearer GM; Shaw S
    J Immunol; 1981 Dec; 127(6):2231-5. PubMed ID: 6975312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides control the gain and loss of allele specificity by mutated MHC class I molecules.
    Hengel H; Burke K; Kyburz D; Zinkernagel RM; Koszinowski UH
    J Immunol; 1995 May; 154(9):4557-64. PubMed ID: 7722309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineation of determinants on HLA-B7 and HLA-B27 that are necessary for cytolytic T cell recognition by using inter- and intra-domain recombinants.
    Healy F; Toubert A; Gomard E; Jordan BR; Levy JP
    J Immunol; 1989 Oct; 143(7):2357-63. PubMed ID: 2476507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.